The authors developed a novel LNP containing mRNA encoding granulocyte-macrophage colony-stimulating factor (Gm-csf mRNA), which can increase plasma GM-CSF levels and peripheral CD4+CD25+FoxP3+ Treg cell populations in PD rats [117]. Here, CSF2 is linked to Parkinson disease.